Clinical Trials | December 13, 2023
Progenesis opens genetic laboratory in New Delhi and AI & Bioinformatics data centre in Chennai
Leading USA based genetic testing brand officially enters the Indian market
Leading USA based genetic testing brand officially enters the Indian market
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Express Scripts to add Zepbound to National Preferred Formulary
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
Subscribe To Our Newsletter & Stay Updated
